Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous aminophylline for prevention of renal dysfunction in neonates with perinatal asphyxia
IRCT20181201041815N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asphyxia neonatorum comparing Aminophylline with Placebo (2 arms). Primary endpoints: Fluid intake, Urine volume and 6 more. Started May 2016; status: completed.
02
Drugs
aminophylline
03
Conditions
asphyxia neonatorum
Beyond the preview
Go deeper on IRCT20181201041815N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181201041815N1.